Paul Conley

Directeur Général chez General Inception

Profil

Paul A.
Conley founded Appfluent Technology, Inc. in 2000, BrightScale, Inc. in 2003, Delix Therapeutics, Inc. in 2019, and General Inception Management LLC in 2020, where he is working as Chief Executive Officer from 2020.
Dr. Conley also currently works at Nortis, Inc., as Director from 2020, Paladin Capital Group, as Managing Director from 2007, Trident Labs, Inc., as Director, Amitree, Inc., as Director from 2017, IONpath, Inc., as Director from 2015, Isolation Bio, Inc., as Director from 2016, Menlo Microsystems, Inc., as Director from 2015, Tasso, Inc., as Director from 2018, RubrYc Therapeutics, Inc., as Director from 2018, Cyberhedge, Inc., as Director from 2018, 1859, Inc., as Director from 2020, Spero Devices, Inc., as Director, Cellsonics, Inc., as Director from 2017, Edifice Health, Inc., as Director from 2020, Alida Biosciences, Inc., as Director from 2020, Constructive Biology Ltd.
(United Kingdom), as Director from 2022, Partillion Bioscience Corp., as Director from 2023, Vertical Venture Partners LLC, as Venture Partner, Lakewood & Co., as Venture Partner, Genoa Ventures LLC, as Partner, OMX Ventures LLC, as Venture Partner, and Lakewood Hughes Group LLC, as Strategic Advisor.
Dr. Conley also formerly worked at Luminus Devices, Inc., as Director from 2008 to 2013, Arxan Technologies, Inc., as Director from 2007 to 2013, WiSpry, Inc., as Director from 2008 to 2015, QuantaLife, Inc., as Director from 2008 to 2011, Shadow Networks, Inc., as Director, 10X Genomics, Inc., as Independent Director, HealthTell, Inc., as Director from 2013 to 2019, Twist Bioscience Corp., as Director from 2013 to 2019, TOMA Biosciences, Inc., as Director from 2014 to 2019, Fixmo, Inc., as Director, and Newlans, Inc., as Director from 2010 to 2015.
Dr. Conley received his undergraduate degree in 1990 and graduate degree in 1993 from the University of Virginia and graduate degree in 1999 from the University of California San Diego.

Postes actifs de Paul Conley

Sociétés	Poste	Début
Paladin Capital Group	Private Equity Investor	01/11/2007
Isolation Bio, Inc.	Directeur/Membre du Conseil	01/02/2016
Trident Labs, Inc.	Directeur/Membre du Conseil	-
Spero Devices, Inc.	Directeur/Membre du Conseil	-
Menlo Microsystems, Inc.	Directeur/Membre du Conseil	01/01/2015
Edifice Health, Inc.	Directeur/Membre du Conseil	01/11/2020
Lakewood & Co.	Private Equity Investor	-
General Inception	Directeur Général	01/02/2020
Nortis, Inc.	Directeur/Membre du Conseil	01/08/2020
░░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░	░░░░░░░ ░░░░░░ ░░░░░░░░	░░░░░░░░░░

Anciens postes connus de Paul Conley

Sociétés	Poste	Fin
░░░ ░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░ ░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░

Formation de Paul Conley

University of California San Diego	Graduate Degree
University of Virginia	Graduate Degree